Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT03321006

Completed

Treating Hearing Loss to Improve Mood and Cognition in Older Adults

Depression | Hearing Loss
NCT05962632

Not yet recruiting

Efficacy and Cost-effectiveness of Different Caries Preventive Protocols

Caries Prevention
NCT03944889

Completed

Quantitative Ultrasound Response of Capsaicin (QUROC)

Central Sensitisation
NCT06639074

Recruiting

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Carcinosarcoma | Primary Peritoneal Carcinosarcoma | Primary Peritoneal Clear Cell Adenocarcinoma | Primary Peritoneal Endometrioid Adenocarcinoma | Advanced Fallopian Tube Carcinoma | Advanced Ovarian Carcinoma | Advanced Primary Peritoneal Carcinoma | Advanced Ovarian Clear Cell Adenocarcinoma
NCT06782932

Recruiting

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Pancreatic Cancer
NCT07272434

Recruiting

Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

Respiratory Syncytial Virus (RSV)
NCT05613127

Not yet recruiting

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs

Hepatitis A | Hep A
NCT04875858

Not yet recruiting

Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients

Pneumococcal Infections
NCT06609811

Completed

The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

Influenza
NCT06183216

Completed

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease
NCT00386542

Completed

Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children

Influenza
NCT06111378

Completed

Effect of OMEGA 3 Fatty Acids on Lactation Period

Lactation Induced
NCT01700179

Completed

Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants

Chronic Hepatitis C Infection
NCT04987294

Terminated

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Chronic Kidney Diseases | Hyperuricemia | Gout
NCT02281383

Completed

Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer

Bladder Cancer | High Risk Superficial
NCT05163834

Completed

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Healthy Volunteers
NCT04051463

Completed

Rhopressa for Corneal Edema Associated With Fuchs Dystrophy

Fuchs Endothelial Dystrophy
NCT04819789

Completed

Digestibility of Fermotein™ (MyDi)

Digestive System
NCT04851977

Completed

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Respiratory Syncytial Virus Infections
NCT03746665

Unknown

Maternal Immunization With MenAfriVac™

Meningitis | Meningococcal
NCT03546634

Completed

Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China

Poliomyelitis
NCT00730847

Terminated

A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.

Human Papillomavirus Infection Leading to Cervical Cancer
NCT02918708

Withdrawn

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants (PINC)

Vaccination | Immunization
NCT02017899

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis
NCT01527383

Completed

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

Herpes Zoster
NCT02127970

Completed

Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Abscess | Cellulitis | Surgical Site Infection | Wound Infection
NCT01155037

Completed

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults (VIP-H1N1)

HIV Infection
NCT01977859

Completed

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

Hypertension | Obesity | Cardiovascular Disease | Diabetes
NCT02675608

Completed

Vaccine Efficacy in Diabetic and Elderly Patients

Inflammation
NCT00389857

Completed

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Influenza
NCT00390884

Completed

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Influenza
NCT01150695

Completed

Phase II Tularemia Vaccine Comparison

Tularaemia
NCT01590459

Completed

24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate

Rheumatoid Arthritis
NCT00895544

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza
NCT01002417

Completed

MCS in the Treatment of Lower Urinary Tract Symptoms (MCS_LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
NCT01823536

Completed

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

Meningococcal Disease
NCT00353977

Completed

Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors

Cytomegalovirus Infections
NCT01189123

Completed

Cell Mediated Immunity in Older Adults (CMI)

Immunity to Influenza Vaccine
NCT00703651

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection
NCT00002817

Unknown

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)
NCT00005630

Completed

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

Lung Cancer
NCT00307008

Completed

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Streptococcus Pneumoniae Vaccines
NCT00003959

Completed

Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia
NCT00620412

Completed

Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy Adults

Healthy
NCT00952861

Withdrawn

Antibiotics in Chronic Obstructive Pulmonary Disease (COPD) (TAExaCOP)

Pulmonary Disease, Chronic Obstructive
NCT00535665

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza
NCT06148025

Recruiting

Antibiotics and Vaccine Immune Responses Study (AVIRS)

Vaccine Response Impaired
NCT06546423

Completed

Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age

Human Metapneumovirus | Human Parainfluenza Virus Type 3
NCT05636436

Active, not recruiting

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Herpes Zoster
NCT05694728

Completed

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Human Papilloma Virus Infection

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations